At a glance
ClinicalIndex Comparison RecordN/ACompleted· 350 enrolled
Drug / intervention
in daily everyday routine practicedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
VAP-PRO-C6. Effectiveness and Tolerability of Venoactive Drugs in Combination Therapy and Their Effect on the Overall Treatment Outcomes in Patients With Chronic Venous Diseases of CEAP Classes C6 in Real Clinical Practice
In Brief
An observational study evaluating in daily everyday routine practice for Chronic Venous Insufficiency. Completed, enrolled 350 participants across 1 site.
Detailed Summary
The VAP-PRO-C6 is a Russian multicenter observational program to be implemented at the routine visits and assessments. The program will include patients with chronic venous disease of CEAP classes C6. This program is planned to be carried out in Russia in 2021-2022.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Venous Insufficiency
CountriesRussia
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedFeb 2021
Enrollment StartMar 2021
Primary CompletionMay 2022
TodayJul 2026
First PostedFeb 17, 2021
Enrollment StartMar 1, 2021
Primary CompletionMay 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 5.4 years ago
Interventions
in daily everyday routine practicedrug
The treatment of patients with chronic venous disease of CEAP classes C6 will be consistent with routine clinical practice, local label for the medical use of drugs and the specific clinical situation.